Raymond James Reiterates Outperform on CME Group, Maintains $320 Price Target
Raymond James analyst Patrick O'Shaughnessy reiterates CME Group (NASDAQ: CME ) with a Outperform and maintains $320 price target.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.